title: Endothelial nitric oxide synthase intron 4a/b polymorphism and early atherosclerotic changes in hypopituitary GH-deficient adult patients.
abstract: OBJECTIVE
  Endothelial nitric oxide synthase (eNOS) intron 4a/b polymorphism is associated with plasma NO concentrations and coronary artery disease/hypertension in various populations. GH deficiency in adulthood predisposes to reduced NO concentrations and premature atherosclerosis. Our aim was to determine whether intron 4a/b polymorphism of eNOS gene influences endothelial function and early atherosclerotic changes in GH-deficient hypopituitary patients.
  
  
  METHODS
  Thirty-three hypopituitary GH-deficient patients on conventional replacement therapy other than GH and 43 age-, sex-, and body mass index (BMI)-matched controls were studied in this cross-sectional case-control study.
  
  
  METHODS
  Early atherosclerotic changes were determined by flow-mediated dilation (FMD) of brachial artery and carotid artery intima-media thickness (IMT). eNOS4a/b polymorphism was detected by PCR.
  
  
  RESULTS
  Hypopituitary patients had significantly higher total/low-density lipoprotein cholesterol and fat mass and lower IGF-I concentrations compared with controls. IMT was significantly higher in patients (0.777+/-0.23 vs 0.639+/-0.17 mm, P<0.01). No significant difference was observed with respect to FMD measurements. eNOS4a/b genotype frequencies were similar between patients and controls. Patients carrying 'a' allele (a/a and a/b) had significantly higher IMT compared with controls carrying 'a' allele and bb genotype (P<0.05). However, logistic regression analysis revealed that presence of hypopituitarism, age> or =45 years, and BMI> or =27.9 kg/m(2) were significant independent predictors of IMT> or =0.65 mm.
  
  
  CONCLUSIONS
  No compelling data are evident to suggest that eNOS4a/b polymorphism modifies the atherosclerotic process in GH-deficient situations. A large case-control study is needed to confirm our findings.
authors.affiliation: Division of Endocrinology, Department of Medicine, Istanbul Faculty of Medicine, Istanbul University, 34390 Capa, Istanbul, Turkey.
authors.forename: Fatma
authors.initials: F
authors.lastname: Sen
authors.forename: Mustafa
authors.initials: M
authors.lastname: Demirturk
authors.forename: Neslihan
authors.initials: N
authors.lastname: Abaci
authors.forename: Ebru
authors.initials: E
authors.lastname: Golcuk
authors.forename: Huseyin
authors.initials: H
authors.lastname: Oflaz
authors.forename: Ali
authors.initials: A
authors.lastname: Elitok
authors.forename: Faruk
authors.initials: F
authors.lastname: Kutluturk
authors.forename: Halim
authors.initials: H
authors.lastname: Issever
authors.forename: Nihan Erginel
authors.initials: NE
authors.lastname: Unaltuna
authors.forename: Nese Colak
authors.initials: NC
authors.lastname: Ozbey
mesh_terms: D000328:Adult; D050197:Atherosclerosis / Q000150:complications / Q000235:genetics*; D016022:Case-Control Studies; D008078:Cholesterol, LDL / Q000097:blood; D003430:Cross-Sectional Studies; D005260:Female; D005838:Genotype; D013006:Growth Hormone / Q000172:deficiency; D006801:Humans; D007018:Hypopituitarism / Q000150:complications / Q000235:genetics*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007438:Introns / Q000235:genetics; D008297:Male; D008875:Middle Aged; D052250:Nitric Oxide Synthase Type III / Q000235:genetics*; D011110:Polymorphism, Genetic
chemical_list: D008078:Cholesterol, LDL; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III